» Articles » PMID: 24297883

Oxytocin Enhances Brain Function in Children with Autism

Overview
Specialty Science
Date 2013 Dec 4
PMID 24297883
Citations 139
Authors
Affiliations
Soon will be listed here.
Abstract

Following intranasal administration of oxytocin (OT), we measured, via functional MRI, changes in brain activity during judgments of socially (Eyes) and nonsocially (Vehicles) meaningful pictures in 17 children with high-functioning autism spectrum disorder (ASD). OT increased activity in the striatum, the middle frontal gyrus, the medial prefrontal cortex, the right orbitofrontal cortex, and the left superior temporal sulcus. In the striatum, nucleus accumbens, left posterior superior temporal sulcus, and left premotor cortex, OT increased activity during social judgments and decreased activity during nonsocial judgments. Changes in salivary OT concentrations from baseline to 30 min postadministration were positively associated with increased activity in the right amygdala and orbitofrontal cortex during social vs. nonsocial judgments. OT may thus selectively have an impact on salience and hedonic evaluations of socially meaningful stimuli in children with ASD, and thereby facilitate social attunement. These findings further the development of a neurophysiological systems-level understanding of mechanisms by which OT may enhance social functioning in children with ASD.

Citing Articles

The Dynamicity of the Oxytocin Receptor in the Brain May Trigger Sensory Deficits in Autism Spectrum Disorder.

Camerino C Curr Issues Mol Biol. 2025; 47(1).

PMID: 39852176 PMC: 11763978. DOI: 10.3390/cimb47010061.


Impact of chronic intranasal oxytocin administration on face expression processing in autistic children: a randomized controlled trial using fMRI.

Moerkerke M, Daniels N, Van der Donck S, Tang T, Prinsen J, Yargholi E Mol Autism. 2024; 15(1):53.

PMID: 39709442 PMC: 11662540. DOI: 10.1186/s13229-024-00635-z.


The impact of the early environment on oxytocin receptor epigenetics and potential therapeutic implications.

Nance M, Sullivan K, Puglia M Pediatr Res. 2024; .

PMID: 39548294 DOI: 10.1038/s41390-024-03563-z.


Neuropeptide therapeutics to repress lateral septum neurons that disable sociability in an autism mouse model.

Borie A, Dromard Y, Chakraborty P, Fontanaud P, Andre E, Francois A Cell Rep Med. 2024; 5(11):101781.

PMID: 39423809 PMC: 11604546. DOI: 10.1016/j.xcrm.2024.101781.


Emerging Treatments and Therapies for Autism Spectrum Disorder: A Narrative Review.

Kaye A, Allen K, Smith Iii V, Tong V, Mire V, Nguyen H Cureus. 2024; 16(7):e63671.

PMID: 39092332 PMC: 11293483. DOI: 10.7759/cureus.63671.


References
1.
Bartz J, Hollander E . Oxytocin and experimental therapeutics in autism spectrum disorders. Prog Brain Res. 2008; 170:451-62. DOI: 10.1016/S0079-6123(08)00435-4. View

2.
Carter C . Oxytocin pathways and the evolution of human behavior. Annu Rev Psychol. 2013; 65:17-39. DOI: 10.1146/annurev-psych-010213-115110. View

3.
Bos P, Panksepp J, Bluthe R, van Honk J . Acute effects of steroid hormones and neuropeptides on human social-emotional behavior: a review of single administration studies. Front Neuroendocrinol. 2011; 33(1):17-35. DOI: 10.1016/j.yfrne.2011.01.002. View

4.
Dadds M, MacDonald E, Cauchi A, Williams K, Levy F, Brennan J . Nasal oxytocin for social deficits in childhood autism: a randomized controlled trial. J Autism Dev Disord. 2013; 44(3):521-31. DOI: 10.1007/s10803-013-1899-3. View

5.
Averbeck B . Oxytocin and the salience of social cues. Proc Natl Acad Sci U S A. 2010; 107(20):9033-4. PMC: 2889126. DOI: 10.1073/pnas.1004892107. View